Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of the Nose for Physical Capacity
NCT04712799Phase 4Unknown
- Sponsor
- Sørlandet sykehus
- Start
- Jan 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of xylometazoline in chronic obstructive pulmonary disease (COPD), sponsored by Sørlandet sykehus. Status: unknown.
02
Drugs
xylometazoline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04712799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712799.